1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. Plus Therapeutics Acquires Azaya Therapeutics

M&A Deal Summary

Plus Therapeutics Acquires Azaya Therapeutics

On January 16, 2017, Plus Therapeutics acquired life science company Azaya Therapeutics

Acquisition Highlights
  • This is Plus Therapeutics’ 2nd transaction in the Life Science sector.
  • This is Plus Therapeutics’ 2nd transaction in the United States.
  • This is Plus Therapeutics’ 1st transaction in Texas.

M&A Deal Summary
Date 2017-01-16
Target Azaya Therapeutics
Sector Life Science
Buyer(s) Plus Therapeutics
Deal Type Add-on Acquisition

Target

Azaya Therapeutics

San Antonio, Texas, United States
Azaya Therapeutics, Inc. is a research, development and manufacturer of nanoparticle therapeutics.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Plus Therapeutics

Houston, Texas, United States
Category Company
Founded 1996
Sector Life Science
Employees21
Revenue 7M USD (2019)
DESCRIPTION

Plus Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Plus Therapeutics was founded in 1996 and is based in Houston, Texas.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Texas M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-10-09 StemSource

Thousand Oaks, California, United States

StemSource, Inc. is a pioneer in the extraction, cryo-preservation and clinical application of adult stem cells derived from adipose (fat) tissue.

Buy -
Mergr

Solution for

Product

Company

Legal